Stay Ahead of Market & Policy Shifts

Financial & Policy Research Insights

Filters

Sector: Healthcare

Shockwave (SWAV): No Higher Rates For Now

Shockwave (SWAV): No Higher Rates For Now

Policy & Legal, Research
In omitting any narrative discussion of Shockwave’s (SWAV) coronary lithotripsy device..
Read more
FDA Action on Aspartame Unlikely

FDA Action on Aspartame Unlikely

Policy & Legal, Research
Recent reports that the World Health Organization (WHO) will reclassify aspartame...
Read more
[CVS, CI, UNH, ELV, HUM]: PBM Policy Noise and Concerns

[CVS, CI, UNH, ELV, HUM]: PBM Policy Noise and Concerns

Policy & Legal, Research
The House Education and Workforce Committee markup of four healthcare bills and the reported...
Read more
European Health Care Equipment & Services: Receding Headwinds

European Health Care Equipment & Services: Receding Headwinds

Fundamental, Research
We see easing headwinds for the European Health Care Equipment & Services industry...
Read more
Revvity: Revitalized for Stronger Growth

Revvity: Revitalized for Stronger Growth

Fundamental, Research
Rebranded as Revvity, it aims at becoming a high growth, high margin firm...
Read more
Health Care REITs Poised for Healthy Returns

Health Care REITs Poised for Healthy Returns

Fundamental, Video
The aging US population and increasing healthcare expenditures...
Read more
[CVS, CI, UNH, ELV]: Entrenchment of PBM Overhang with More Bills Expected

[CVS, CI, UNH, ELV]: Entrenchment of PBM Overhang with More Bills Expected

Policy & Legal, Research
No relief for PBMs [CVS (CVS), Cigna (CI),...
Read more
May 2023 PDUFA Calendar

May 2023 PDUFA Calendar

Policy & Legal, Research
Delays in approvals due to disrupted work schedules at FDA because of the coronavirus...
Read more
Silk Road (SILK): Competition & Coverage

Silk Road (SILK): Competition & Coverage

Policy & Legal, Research
Amid investor fears of competitive risks to Silk Road Medical’s (SILK)’s TCAR procedure...
Read more
April 2023 PDUFA Calendar

April 2023 PDUFA Calendar

Policy & Legal, Research
Disrupted work schedules at FDA result in approval delays...
Read more